Download Files:
Products Details
Product Description
– c-ABL-IN-4 is a potent inhibitor of c-Abl. Activation of c-Abl has been implicated in various diseases, notably cancer. c-ABL-IN-4 has the potential for the research of neurodegenerative diseases (amyotrophic lateral sclerosis (ALS) and Parkinson’s disease (PD) and cancer (extracted from patent WO2021048567A1, compound 54)[1].
Web ID
– HY-146530
Shipping
– Room temperature
Applications
– Cancer-programmed cell death
Molecular Formula
– C18H11ClF3N3O3
References
– [1] Michael J. RAWLING, et al. New compounds and methods. Patent WO2021048567A1.
CAS Number
– 2626934-68-5
Molecular Weight
– 409.75
SMILES
– O=C(C1=CN(C(C=C1)=O)C2=CN=CC(F)=C2)NC3=CC=C(C=C3)OC(F)(Cl)F
Clinical Information
– No Development Reported
Research Area
– Cancer; Neurological Disease
Solubility
– 10 mM in DMSO
Target
– Others
Pathway
– Others
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
